CART-19 Immunotherapy in Mantle Cell Lymphoma
NCT02081937
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
2
Enrollment
OTHER
Sponsor class
Conditions
Hematopoietic/Lymphoid Cancer
Non-hodgkin Lymphoma,B Cell
Mantle Cell Lymphoma
Interventions
BIOLOGICAL:
anti-CD19-CAR vector-transduced T cells
Sponsor
Chinese PLA General Hospital